Image

Use of Surface Electromyography as a Tools to Predict Upper Extremity Recovery Function After Stroke

Use of Surface Electromyography as a Tools to Predict Upper Extremity Recovery Function After Stroke

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Hypothesis :

Based on the framework and premises above, the hypothesis is formulated as follows: H0 : surface electromyography parameters cannot predicts upper extremity motor function recovery in stroke patients H1: surface electromyography parameters can predicts upper extremity motor function recovery in stroke patients

Description

Study design and setting This study is an analytic quantitative observational study, to analyse the quantification of Manual Muscle Test score, Fugl Mayer Assessment-Upper Extremity score and electrical signals of the anterior deltoid, biceps, triceps, wrist flexors and wrist extensors muscles based on contractions, length of contraction and amplitude parameters in patients with acute phase stroke. This study performed at HasanSadikin Hospital between February 2024 - July 2024. Study participants Potential participants will be recruited by the main researcher

Inclusion criteria:

  1. Patients who are hospitalized with upper extremity weakness due to stroke on the same side which confirmed with computed tomography scan or structural magnetic resonance imaging, in the acute phase
  2. Men and women aged more than 18 years old
  3. Willing to participate

Exclusion criteria:

  1. Cognitive impairment (MoCA-Ina score less than 26)
  2. Impaired consciousness (GCS score less than 15)
  3. Unstable medical conditions at time of hospitalization
  4. Patients with pacemaker
  5. Having other injury or dysfunction in the impaired side of upper extremity that caused restrictions on the range of joint movement and muscle weakness, such as fractures, periarthritis, or moderate-severe pain
  6. Diagnosis of other neurological disease or disorders in addition to stroke (e.g., traumatic brain injury, neuropathy or radiculopathy)
  7. Get treated in isolation room
  8. Hypersensitivity to gel electrodes

Drop out criteria:

  1. Unable to do 2 or more follow up session
  2. Withdrawn by themselves

Confounding factor:

  1. Stroke location
  2. Stroke size
  3. Spasticity
  4. Rehabilitation program
  5. Compliance rehabilitation
  6. Stroke risk factor

Sampling Technique The method of sampling based on consecutive samplings, that is, all stroke patients who meet the inclusion and exclusion criteria during the duration of the study.

Based on the formula above, the minimum sample size for this research is adequate, so the minimum sample size is 30 samples.

Eligibility

Inclusion Criteria:

  1. Patients who are hospitalized with upper extremity weakness due to stroke on the same side which confirmed with computed tomography (CT) scan or structural magnetic resonance imaging (MRI), in the acute phase
  2. Men and women aged more than 18 years old
  3. Willing to participate

Exclusion Criteria:

  1. Cognitive impairment (MoCA-Ina score less than 26)
  2. Impaired consciousness (GCS score less than 15)
  3. Unstable medical conditions at time of hospitalization
  4. Patients with pacemaker
  5. Having other injury or dysfunction in the impaired side of upper extremity that caused restrictions on the range of joint movement and muscle weakness, such as fractures, periarthritis, or moderate-severe pain
  6. Diagnosis of other neurological disease or disorders in addition to stroke (e.g., traumatic brain injury, neuropathy or radiculopathy)
  7. Get treated in isolation room
  8. Hypersensitivity to gel electrodes

Study details
    Upper Extremity Paresis
    Muscle Contracture Upper Arm
    Stroke

NCT06574737

Universitas Padjadjaran

14 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.